Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
XOMA Corp - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
XOMA
Nasdaq
8731
https://www.xoma.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for XOMA Corp
Shareholders in XOMA (NASDAQ:XOMA) are in the red if they invested five years ago
- May 16th, 2023 1:29 pm
XOMA Reports First Quarter 2023 Financial Results and Provides Update on the Acceleration of its Differentiated Royalty Monetization Strategy
- May 9th, 2023 11:30 am
XOMA to Present at H.C. Wainwright BioConnect Investor Conference
- Apr 26th, 2023 11:30 am
XOMA Acquires Cashflow-Generating Asset for its Royalty and Milestone Portfolio
- Mar 30th, 2023 11:30 am
XOMA Declares Quarterly Preferred Stock Dividends
- Mar 21st, 2023 11:30 am
XOMA Full Year 2022 Earnings: Revenues Beat Expectations, EPS In Line
- Mar 10th, 2023 10:36 am
XOMA Reports Full-Year 2022 Financial Results and Provides Update to the Acceleration of its Differentiated Royalty Monetization Strategy
- Mar 9th, 2023 12:30 pm
XOMA Corporation's (NASDAQ:XOMA) largest shareholders are individual investors with 37% ownership, hedge funds own 32%
- Mar 6th, 2023 1:28 pm
XOMA to Present at 43rd Annual Cowen Health Care Conference
- Feb 28th, 2023 12:30 pm
XOMA Announces New Employment Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Jan 7th, 2023 12:00 am
New Executive Leadership Team Appointed to Accelerate XOMA’s Differentiated Royalty Monetization Strategy
- Jan 4th, 2023 12:30 pm
XOMA (NASDAQ:XOMA) shareholders have endured a 39% loss from investing in the stock five years ago
- Dec 7th, 2022 12:44 pm
XOMA Acquires Royalty and Milestone License to Ebopiprant, a Preterm Labor Asset, Being Developed by Organon
- Nov 22nd, 2022 12:01 pm
XOMA Corporation's (NASDAQ:XOMA) Stock Has Been Sliding But Fundamentals Look Strong: Is The Market Wrong?
- Nov 6th, 2022 2:24 pm
Xoma (XOMA) Reports Q3 Loss, Misses Revenue Estimates
- Nov 3rd, 2022 1:05 pm
XOMA Reports Third Quarter 2022 Financial Results and Highlights Recent Operational Events
- Nov 3rd, 2022 11:30 am
Hedge funds own 31% of XOMA Corporation (NASDAQ:XOMA) shares but individual investors control 40% of the company
- Sep 27th, 2022 12:30 pm
XOMA to Present at H.C. Wainwright 24th Annual Global Investment Conference
- Sep 7th, 2022 11:30 am
Is There An Opportunity With XOMA Corporation's (NASDAQ:XOMA) 49% Undervaluation?
- Sep 1st, 2022 10:20 am
Time To Worry? Analysts Are Downgrading Their XOMA Corporation (NASDAQ:XOMA) Outlook
- Aug 11th, 2022 10:22 am
Scroll